Company intelligence / Profile preview

Oramed Pharmaceuticals Inc.

Jerusalem, Jerusalem District, Israeloramed.com ↗
Ownership
Public · ORMP
Employees
~30
Development stage
Phase 3
01

Overview

Oramed Pharmaceuticals developed a proprietary oral protein/peptide drug delivery platform. Its flagship product, an oral insulin capsule for type 2 diabetes, reached Phase 3 trials under FDA oversight but did not meet its primary endpoint in January 2023. The company continues to develop additional pipeline candidates—including an oral GLP‑1 analog capsule and a joint venture developing an oral COVID‑19 vaccine—leveraging its POD™ technology to transform injectable therapies into convenient oral formulations.

Therapeutic areas
GastroenterologyEndocrinologyMetabolic DisordersInfectious Diseases
Modalities
Proteins (oral delivery)Peptides (oral delivery)Small molecules (potentially, via platform extension)
Industry
Biotech
02

Drug pipeline

8 assets

ORMD-0801

3

7 more assets in the full pipeline.

Request access →
03

Partnerships

Premas Biotech Pvt. Ltd. – Partner in Oravax Medical JV for the development of the oral COVID–19 vaccine

Beyond the preview

Go deeper on Oramed Pharmaceuticals Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oramed Pharmaceuticals Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call